Phase i study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease

Sarah Nikiforow, Haesook T. Kim, Bhavjot Bindra, Sean McDonough, Brett Glotzbecker, Philippe Armand, John Koreth, Vincent T. Ho, Edwin P. Alyea, Bruce R. Blazar, Jerome Ritz, Robert J. Soiffer, Joseph H. Antin, Corey S. Cutler

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science